In 1999, STORZ MEDICAL was the first manufacturer worldwide to introduce a cardiological shock wave system for the treatment of refractory angina pectoris. During the last few years, the company has conducted ongoing research in close co-operation with leading medical institutes and continuously improved shock wave therapy for cardiological applications.
Today, many renowned therapy centres use the innovative MODULITH® SLC with great success in the treatment of Non-revascularizable Angina Pectoris, Ischemic Heart Disease (HF), No-reflow after PCI, Diffuse Coronary Artery Disease.
CSWT Products for Angina Pectoris
Literature
Patient Information
